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Abstract
Among the preschool children who wheeze two different groups can be identify: children who have
a viral infection and those who respond to multiple triggers, such as exercise or allergens.
To distinguish between these different phenotypes of wheezing, and consequently choose therapy
represents a major challenge for pediatricians.
Transient wheezers conditions do not improve with maintenance treatment with ICS. On the
other hand they are definitely useful in children with wheeze/asthma.
Increasing evidence is in favor of the potential role of leukotriene receptor antagonists in preschool
children with recurrent wheezing.
Oral steroid has been demonstrated not to be indicated to control acute wheezing, unless severe
disease is expected in non-atopic children.
The early phenotyping of preschool wheezers, upon which the appropriate treatment should be
based, represents a challenging issue in the paediatric practice.
Phenotyping of the wheezing
Wheezing and cough are frequently observed in preschool
children, in many cases related to a respiratory tract infec-
tion.
These situations represent a major challenge in the prac-
tice of paediatricians since, at present, it is very hard to dis-
tinguish between the different phenotypes which underlie
an apparently similar clinical presentation.
In fact, among the preschool children who wheeze, at
least two different groups can be identified, i.e. children
who wheeze on the basis of a viral trigger and those who
respond to multiple triggers, the latter being somehow ref-
erable to the asthmatic wheezing [1].
The temporal pattern for viral wheezing is commonly
reported as episodic, with periods free of symptoms
between episodes, and is reported to be concomitant with
a viral infection of the airways.
In contrast, children with multiple trigger wheezing,
though being highly responsive to viral infections which
represent the most common trigger for their symptoms,
also wheeze when exposed to a variety of other triggers,
such as exercise or allergens [1].
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Cohort studies have suggested that some clinical charac-
teristics can help in distinguishing among the different
phenotypes of preschool wheezers [2], but the application
of such parameters cannot be considered conclusive for
the clinical purposes.
More recently, studies based upon a latent class analysis
have demonstrated that considering clusters of symptoms
may contribute to the identification of different pheno-
types among children with respiratory disorders [3].
The clinical approach to preschool wheezers
From a practical point of view, the difficulty in allocating
an individual patient within a specific phenotype repre-
sent a major task for paediatricians not only in terms of
diagnostic procedures but consequently also, and even
more importantly, in terms of treatment strategy.
In particular, in the last few months, a body of discussion
has been raised around the issue of the use of corticoster-
oids, either systemic or inhaled in the treatment of acute
wheezing in preschool children.
The use of inhaled or oral corticosteroids in preschool
wheezers is widely diffuse in the paediatric practice,
mainly based upon the recommendation of guidelines for
elder asthmatic children.
Some recent publications has looked for a deeper insight
into the challenging issue of the use of either systemic or
inhaled corticosteroids in younger children with wheezing.
In particular, Panickard et al have studied the role of oral
prednisolone in wheezing induced by viral infection [4].
They have randomly treated 687 preschool children with
an attack of wheezing associated with viral infection with
either prednisolone or placebo for 5-days.
The results of this study definitely showed that oral corti-
costeroids cannot be proposed as an effective treatment in
children with viral induced wheezing and, therefore, it no
longer allows the indiscriminate use of such a common
treatment in this situation, at least in mild-to-moderate
conditions.
As clearly pointed in the accompanying editorial by Bush
[5], the results of this study are to be considered in the
frame of the characteristics of the study population, i.e.
preschool children who didn't present with the classic
atopic asthma phenotype, which, on the other hand, is
positively recognized to be responsive to corticosteroid
treatment.
Therefore, even if it has to be taken into consideration that
also severe episodic viral wheezing may need a treatment
with oral steroid, the evidence from the study by Panickar
and co-workers no longer justify the use of oral steroids in
non-atopic children for whom a severe prognosis is not
anticipated [5]
Inhaled corticosteroid courses are proposed even more
frequently than oral ones in children presenting with
wheeze.
Ducharme et al. have demonstrated that high dose
inhaled fluticasone (750 mcg/bid) can be somewhat effec-
tive in preventing the use of oral corticosteroids in pre-
school children with moderate-to-severe virus -induced
wheezing [6]. The apparent paradox of a better response
to the administration of an inhaled corticosteroid in a
population with clinical characteristics very similar to
those of the group receiving oral prednisone in the Pan-
ickar's study could be speculatively explained by a vaso-
constrictive effect which is potentially resulting in an anti-
edema effect at the site of the bronchial mucosa [5], rather
than due to an anti-inflammatory effect.
Nevertheless, the Authors observed a potential risk of side
effects on growth in children treated with a such high dose
of fluticasone and clearly warned about the use of this
therapeutic strategy in children.
On the basis of the hypothesis of an anti-oedema effect of
high doses of inhaled corticosteroid, other drugs with a
vasoconstrictive effect could be even more effective in
controlling viral wheezing, with potentially lower risk of
side effects, thus warranting further studies with the aim
to address this specific question.
If the issue of using corticosteroid in acute episodes of
wheezing in preschool children deserved the publication
of the two above reported studies, a meta-analysis aiming
to evaluate the efficacy of prolonged treatment with
inhaled corticosteroids in preschool children with recur-
rent episodes of wheezing or asthma was recently pub-
lished in the Pediatrics [7].
The Authors considered 29 randomized trials, including
3.592 children who were receiving for at least four weeks
of inhaled corticosteroids for their frequent wheezing epi-
sodes. They concluded that ICS are useful in such paediat-
ric population in terms of reduction of exacerbations,
symptoms and lung function improvement.
Nevertheless, though the conclusions of this analysis are
presented for the pooled group of wheezing and asth-
matic children, they are mostly driven by studies includ-
ing patients with pronounced asthmatic features as
previously described by Castro-Rodriguez et al. [2], for
whom the effectiveness of ICS treatment is widely
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In particular, the study by Guilbert et al [8], which
weighted 22,8% for the RR of wheeze/asthma exacerba-
tion (WAE), was designed to select and treat children with
a positive asthma predictive index.
Also in the study by Baker et al. [9], which weighted for
15.1% in the meta-analysis by Castro Rodriguez and Rod-
rigo [7], were considered only children with a specific
diagnosis of persistent asthma.
In the study by Roorda et al [10], accounting for 13.7% in
the meta-analysis, it is clearly indicated that a significant
response to ICS treatment was observed in the children
with frequent symptoms, a family history of asthma, or
both, but not in those without a family history. Similar
consideration can be extended to a number of further
studies with lighter weight in the analysis.
Therefore, the conclusion that ICSs are useful in infants
and preschool children with wheeze/asthma can repre-
sent a misleading message to the reader regarding the
potential usefulness of a maintenance treatment with ICSs
in the group of transient wheezers.
To the best of our knowledge, for this group, at present,
there is no indication that a maintenance treatment with
ICCs can be effective in reducing the number or the sever-
ity of wheezing [11].
Conclusions
The main clinical dilemma for paediatricians dealing with
preschool children with wheezing is represented by the
difficulty to predict the future development of the disease
in the individual patients. At the present we know that the
response to systemic and inhaled steroids in this age
group is poor, due to the prevalence of viral wheeze in
these children[12].
Therefore, at present, the therapeutic options potentially
available for preschool children with episodic non-atopic
wheeze are β2-agonists to control the re-exacerbations,
along with intermittent or prophylactic leukotriene recep-
tors antagonists, whereas high dose inhaled corticoster-
oids are not recommended and oral corticosteroids
should be considered only in severe children in hospital
setting [5].
We agree with Saglani and Bush that asthma in preschool
children represents the next challenge for pediatricians
and that there is a desperate need for both a more efficient
phenotypic process and new therapeutic options for these
children [13].
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